Perspective Therapeutics Files 8-K
Ticker: CATX · Form: 8-K · Filed: Dec 1, 2025 · CIK: 728387
Sentiment: neutral
Topics: 8-k, filing, regulatory
TL;DR
Perspective Therapeutics filed an 8-K on 12/1/25. Check for updates.
AI Summary
Perspective Therapeutics, Inc. filed an 8-K on December 1, 2025, reporting other events and financial statements. The company, formerly known as Isoray, Inc., is incorporated in Delaware and headquartered in Seattle, Washington.
Why It Matters
This filing indicates that Perspective Therapeutics, Inc. has made a regulatory submission to the SEC, which may contain important updates on the company's operations or financial status.
Risk Assessment
Risk Level: low — This is a routine filing with no immediate indication of significant positive or negative events.
Key Numbers
- 001-33407 — SEC File Number (Identifies the company's filing history with the SEC.)
- 41-1458152 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Perspective Therapeutics, Inc. (company) — Registrant
- Isoray, Inc. (company) — Former company name
- 20251201 (date) — Date of report
- 2401 Elliott Avenue Suite 320 (location) — Principal executive offices address
- Seattle, Washington (location) — Principal executive offices city and state
FAQ
What specific 'Other Events' are detailed in this 8-K filing?
The provided text does not specify the 'Other Events' beyond listing it as an item information category.
What is the nature of the 'Financial Statements and Exhibits' being filed?
The filing indicates that financial statements and exhibits are part of this 8-K, but their specific content is not detailed in the provided excerpt.
When was Perspective Therapeutics, Inc. previously known as Isoray, Inc.?
The filing indicates a former company name of 'Isoray, Inc.' with a date of name change of '20181231'.
What is the primary business SIC code for Perspective Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code listed is 2834, which corresponds to Pharmaceutical Preparations.
Where are Perspective Therapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 2401 Elliott Avenue, Suite 320, Seattle, Washington, 98121.
Filing Stats: 413 words · 2 min read · ~1 pages · Grade level 10.6 · Accepted 2025-12-01 16:13:44
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value CATX NYSE American LLC
Filing Documents
- catx-20251201.htm (8-K) — 44KB
- catx-ex99_1.htm (EX-99.1) — 22KB
- catx-ex99_1s1.jpg (GRAPHIC) — 131KB
- catx-ex99_1s2.jpg (GRAPHIC) — 537KB
- catx-ex99_1s3.jpg (GRAPHIC) — 267KB
- catx-ex99_1s4.jpg (GRAPHIC) — 193KB
- catx-ex99_1s5.jpg (GRAPHIC) — 216KB
- catx-ex99_1s6.jpg (GRAPHIC) — 169KB
- catx-ex99_1s7.jpg (GRAPHIC) — 288KB
- catx-ex99_1s8.jpg (GRAPHIC) — 253KB
- catx-ex99_1s9.jpg (GRAPHIC) — 109KB
- catx-ex99_1s10.jpg (GRAPHIC) — 250KB
- catx-ex99_1s11.jpg (GRAPHIC) — 273KB
- catx-ex99_1s12.jpg (GRAPHIC) — 334KB
- catx-ex99_1s13.jpg (GRAPHIC) — 241KB
- catx-ex99_1s14.jpg (GRAPHIC) — 343KB
- catx-ex99_1s15.jpg (GRAPHIC) — 261KB
- catx-ex99_1s16.jpg (GRAPHIC) — 258KB
- catx-ex99_1s17.jpg (GRAPHIC) — 132KB
- catx-ex99_1s18.jpg (GRAPHIC) — 227KB
- catx-ex99_1s19.jpg (GRAPHIC) — 392KB
- catx-ex99_1s20.jpg (GRAPHIC) — 120KB
- catx-ex99_1s21.jpg (GRAPHIC) — 303KB
- catx-ex99_1s22.jpg (GRAPHIC) — 316KB
- catx-ex99_1s23.jpg (GRAPHIC) — 207KB
- catx-ex99_1s24.jpg (GRAPHIC) — 276KB
- catx-ex99_1s25.jpg (GRAPHIC) — 244KB
- catx-ex99_1s26.jpg (GRAPHIC) — 298KB
- catx-ex99_1s27.jpg (GRAPHIC) — 253KB
- catx-ex99_1s28.jpg (GRAPHIC) — 252KB
- catx-ex99_1s29.jpg (GRAPHIC) — 279KB
- catx-ex99_1s30.jpg (GRAPHIC) — 204KB
- catx-ex99_1s31.jpg (GRAPHIC) — 379KB
- catx-ex99_1s32.jpg (GRAPHIC) — 121KB
- catx-ex99_1s33.jpg (GRAPHIC) — 258KB
- catx-ex99_1s34.jpg (GRAPHIC) — 311KB
- catx-ex99_1s35.jpg (GRAPHIC) — 313KB
- catx-ex99_1s36.jpg (GRAPHIC) — 214KB
- catx-ex99_1s37.jpg (GRAPHIC) — 359KB
- catx-ex99_1s38.jpg (GRAPHIC) — 247KB
- catx-ex99_1s39.jpg (GRAPHIC) — 255KB
- catx-ex99_1s40.jpg (GRAPHIC) — 320KB
- catx-ex99_1s41.jpg (GRAPHIC) — 134KB
- catx-ex99_1s42.jpg (GRAPHIC) — 290KB
- catx-ex99_1s43.jpg (GRAPHIC) — 302KB
- catx-ex99_1s44.jpg (GRAPHIC) — 286KB
- catx-ex99_1s45.jpg (GRAPHIC) — 228KB
- catx-ex99_1s46.jpg (GRAPHIC) — 218KB
- catx-ex99_1s47.jpg (GRAPHIC) — 218KB
- catx-ex99_1s48.jpg (GRAPHIC) — 314KB
- catx-ex99_1s49.jpg (GRAPHIC) — 270KB
- catx-ex99_1s50.jpg (GRAPHIC) — 95KB
- catx-ex99_1s51.jpg (GRAPHIC) — 267KB
- catx-ex99_1s52.jpg (GRAPHIC) — 232KB
- catx-ex99_1s53.jpg (GRAPHIC) — 201KB
- catx-ex99_1s54.jpg (GRAPHIC) — 97KB
- catx-ex99_1s55.jpg (GRAPHIC) — 301KB
- catx-ex99_1s56.jpg (GRAPHIC) — 85KB
- catx-ex99_1s57.jpg (GRAPHIC) — 344KB
- catx-ex99_1s58.jpg (GRAPHIC) — 333KB
- catx-ex99_1s59.jpg (GRAPHIC) — 348KB
- catx-ex99_1s60.jpg (GRAPHIC) — 300KB
- catx-ex99_1s61.jpg (GRAPHIC) — 297KB
- catx-ex99_1s62.jpg (GRAPHIC) — 264KB
- catx-ex99_1s63.jpg (GRAPHIC) — 219KB
- catx-ex99_1s64.jpg (GRAPHIC) — 226KB
- catx-ex99_1s65.jpg (GRAPHIC) — 303KB
- catx-ex99_1s66.jpg (GRAPHIC) — 321KB
- catx-ex99_1s67.jpg (GRAPHIC) — 239KB
- catx-ex99_1s68.jpg (GRAPHIC) — 305KB
- 0001193125-25-303895.txt ( ) — 24186KB
- catx-20251201.xsd (EX-101.SCH) — 25KB
- catx-20251201_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On December 1, 2025, Perspective Therapeutics, Inc. updated its corporate presentation. A copy of the presentation is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 8.01.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Corporate Presentation . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PERSPECTIVE THERAPEUTICS, INC. Date: December 1, 2025 By: /s/ Joel Sendek Joel Sendek Chief Financial Officer